Hematologic Oncology | Specialty

The OncLive Hematology Oncology condition center page is a comprehensive resource for clinical news and expert insights on various hematologic malignancies, including leukemias, lymphomas, myeloproliferative neoplasms, multiple myeloma, and much more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in hematologic cancers.

Advances in the Treatment of Relapsed or Refractory Hairy Cell Leukemia

July 12th 2019

After decades of quiescence, the therapeutic landscape of hairy cell leukemia is undergoing rapid evolution.

Research Abounds Across Lymphomas, But More Work Remains

July 11th 2019

Jing-Zhou Hou, MD, PhD, highlights the research being conducted in the realm of lymphoma, including positive and negative trials that have read out in the space, and provides insight into novel approaches under investigation.

Devimistat Could Have Practice-Changing Potential in Burkitt Lymphoma

July 11th 2019

Ariela Noy, MD, discusses a phase II trial of devimistat in Burkitt lymphoma and other lymphomas, and describes the unique mechanism of action of the agent.

Hairy Cell Leukemia: A Review of Epidemiology and Disease Presentation

July 11th 2019

Despite the significant progress that has been made regarding the incidence, risk factors, and symptoms of hairy cell leukemia, diagnosis remains a challenge, due in part to the low incidence of the disease.

A Rare but Treatable Disease: Therapeutic Considerations for Hairy Cell Leukemia

July 11th 2019

Martin S. Tallman, MD, discusses the biology, presentation, and available therapeutic options in hairy cell leukemia.

Hairy Cell Leukemia Pathogenesis, Diagnosis, and Prognosis

July 10th 2019

The pathogenesis, diagnostic criteria, staging, and prognosis of hairy cell leukemia, an uncommon indolent B-cell lymphoid neoplasm, is examined.

Challenges in the Treatment of Follicular Lymphoma

July 9th 2019

Looking Ahead in the Treatment of Follicular Lymphoma

July 9th 2019

The SWOG 1608 and Phase Ib/II Trials for Follicular Lymphoma

July 9th 2019

The GADOLIN and GALEN Trials for Follicular Lymphoma

July 9th 2019

Second-Line Treatment for Follicular Lymphoma

July 9th 2019

Untreated Follicular Lymphoma and the Role of MRD Testing

July 9th 2019

Frontline Treatment for Follicular Lymphoma

July 9th 2019

Risk Stratification in Follicular Lymphoma

July 9th 2019

Treating Follicular Lymphoma: Addressing Unmet Needs

July 9th 2019

Treating Relapsed/Refractory Follicular Lymphoma

July 9th 2019

Obinutuzumab Versus Rituximab in Frontline FL

July 9th 2019

FL: Interpreting and Applying GALLIUM Data in Practice

July 9th 2019

The GALLIUM Study in Follicular Lymphoma

July 9th 2019

The National LymphoCare Study in Follicular Lymphoma

July 9th 2019